RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Vote I think people over analyze everything here. I own several other micro/small cap stocks (non-biotech) - they all suffer from the same thing - they are small cap stocks with a very small audience. But over time, certain events put them on the radar. I am convinced this will happen here, as there is significant value here and it doesn't take much effort to see it - but some will continue to get frustrated because they don't understand small caps and expect them to trade like large caps or the market. Patience is key, and the fact that only 2 years ago the stock was at $14 is eating away at folks - but guess what - a lot can change in 2 years, so buy more at these levels and stop overanalyzing!